CN103356612B - 包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物 - Google Patents

包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物 Download PDF

Info

Publication number
CN103356612B
CN103356612B CN201310230786.1A CN201310230786A CN103356612B CN 103356612 B CN103356612 B CN 103356612B CN 201310230786 A CN201310230786 A CN 201310230786A CN 103356612 B CN103356612 B CN 103356612B
Authority
CN
China
Prior art keywords
active substance
alone
carveol
concentration
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201310230786.1A
Other languages
English (en)
Chinese (zh)
Other versions
CN103356612A (zh
Inventor
阿德南·雷梅尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advanced Scientific Developments
Original Assignee
Advanced Scientific Developments
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Scientific Developments filed Critical Advanced Scientific Developments
Publication of CN103356612A publication Critical patent/CN103356612A/zh
Application granted granted Critical
Publication of CN103356612B publication Critical patent/CN103356612B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201310230786.1A 2005-05-13 2006-05-15 包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物 Active CN103356612B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
WOPCT/IB2005/001313 2005-05-13
PCT/IB2005/001313 WO2006120494A1 (fr) 2005-05-13 2005-05-13 Combinaison pharmaceutique comprenant un antibacterien et une substance active choisie parmi le carveol, le thymol, l’eugenol, le borneol et les carvacrol

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2006800164912A Division CN101175531B (zh) 2005-05-13 2006-05-15 包含一种抗菌药以及一种选自香芹醇、麝香草酚、丁香酚、冰片、香芹酚的活性物质的药物组合物

Publications (2)

Publication Number Publication Date
CN103356612A CN103356612A (zh) 2013-10-23
CN103356612B true CN103356612B (zh) 2015-04-15

Family

ID=35427275

Family Applications (3)

Application Number Title Priority Date Filing Date
CN2011101912078A Active CN102319246B (zh) 2005-05-13 2006-05-15 包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物
CN201310230786.1A Active CN103356612B (zh) 2005-05-13 2006-05-15 包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物
CN2006800164912A Active CN101175531B (zh) 2005-05-13 2006-05-15 包含一种抗菌药以及一种选自香芹醇、麝香草酚、丁香酚、冰片、香芹酚的活性物质的药物组合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN2011101912078A Active CN102319246B (zh) 2005-05-13 2006-05-15 包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2006800164912A Active CN101175531B (zh) 2005-05-13 2006-05-15 包含一种抗菌药以及一种选自香芹醇、麝香草酚、丁香酚、冰片、香芹酚的活性物质的药物组合物

Country Status (13)

Country Link
US (1) US20080214518A1 (enExample)
EP (1) EP1879655B1 (enExample)
JP (1) JP5410748B2 (enExample)
CN (3) CN102319246B (enExample)
BR (1) BRPI0610125B8 (enExample)
CA (1) CA2606875C (enExample)
DK (1) DK1879655T3 (enExample)
EA (1) EA014069B1 (enExample)
ES (1) ES2530963T3 (enExample)
MA (1) MA29606B1 (enExample)
PT (1) PT1879655E (enExample)
TN (1) TNSN07424A1 (enExample)
WO (2) WO2006120494A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918571B1 (fr) * 2007-07-10 2013-01-11 Aroma Tech Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales
ES2716474T3 (es) 2007-10-26 2019-06-12 Avivagen Inc Composiciones y métodos para mejorar la respuesta inmunitaria
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
WO2010124391A1 (en) 2009-04-30 2010-11-04 Chemaphor Inc. Methods and compositions for improving the health of animals
EA019746B1 (ru) 2009-09-24 2014-05-30 Юнилевер Нв Противомикробная композиция, содержащая эвгенол, терпинеол и тимол, и способ дезинфицирования поверхности
CN103354741B (zh) 2010-12-07 2016-01-13 荷兰联合利华有限公司 口腔护理组合物
EP2773315B1 (en) 2011-11-03 2015-07-08 Unilever N.V. A personal cleaning composition
EP2787828B1 (en) 2011-12-06 2016-09-07 Unilever N.V. Antimicrobial composition
CN102670619B (zh) * 2012-05-08 2014-02-19 广东药学院 一种头孢氨苄冰片组合物
CN102670598B (zh) * 2012-05-08 2014-07-16 广东药学院 一种青霉素冰片组合物在制备抗菌药物中的应用
CN103146255B (zh) * 2013-02-25 2014-07-09 厦门吉宏包装科技有限公司 一种抑菌驱螨印刷底油母液和由母液制作的印刷底油及其制备方法
CN105357971A (zh) * 2013-05-07 2016-02-24 凯敏工业公司 含有香芹酚和麝香草酚的抗微生物组合物
FR3025718A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
FR3025719A1 (fr) 2014-09-15 2016-03-18 Septeos Antimicrobiens potentialises
WO2016081594A1 (en) * 2014-11-19 2016-05-26 The General Hospital Corporation System and method for photo-dynamic procedure
HRP20201828T1 (hr) * 2014-12-18 2021-01-08 Helperby Therapeutics Limited Nova kombinacija i uporaba
JP2017538749A (ja) * 2014-12-18 2017-12-28 ヘルパービー セラピューティクス リミテッドＨｅｌｐｅｒｂｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ 抗微生物剤の組み合わせおよび微生物感染の治療におけるそれらの使用
CN109512998A (zh) * 2016-03-04 2019-03-26 广州英赛特生物技术有限公司 含氧碳氢衍生物的酯化衍生物作为多粘菌素的协同增效剂的应用
FR3048612B1 (fr) 2016-03-14 2020-10-02 Septeos Tulathromycine potentialisee
US11872216B2 (en) 2016-06-02 2024-01-16 Advanced Scientific Developments Pharmaceutical formulation comprising cineole and amoxicillin
GB201904963D0 (en) * 2019-04-08 2019-05-22 Anpario Plc Composition for reducing antimicrobial resistance
EP4069221B1 (fr) 2019-12-04 2024-05-08 Pranarôm International S.A. Procede de transformation d'une huile essentielle
KR102848354B1 (ko) * 2023-02-13 2025-08-21 경상국립대학교산학협력단 테트라사이클린계 항생제와 시너지 효과를 가지는 바닐린 또는 카바크롤을 유효성분으로 포함하는 조성물 및 이의 용도

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO2000010390A1 (en) * 1996-02-20 2000-03-02 Badaway Mohammed A Method of enhancing the antimicrobial properties of antibacterial antibiotics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317775A (en) * 1980-01-07 1982-03-02 Hoffmann-La Roche Inc. Amoxicillin derivatives
DE3634697A1 (de) * 1986-10-11 1988-04-21 Dentaire Ivoclar Ets Dentalwerkstoff zur bekaempfung von karies und parodontose
US5213615A (en) * 1986-10-11 1993-05-25 Ivoclar Ag Dental material and method for the control of caries and paradentitis
FR2697133B1 (fr) * 1992-10-28 1995-01-13 Transbiotech Composition biocide et/ou biostatique et ses applications.
US5308873A (en) * 1992-12-18 1994-05-03 Doyle E. Chastain Method of killing yeast and fungi with carveol
US5916566A (en) * 1995-06-07 1999-06-29 Avmax, Inc. Use of benzoin gum to inhibit P-glycoprotein-mediated resistance of pharmaceutical compounds
US6319507B1 (en) * 1997-05-02 2001-11-20 Kobo Products, Inc. Agar gel bead composition and method
US6025400A (en) * 1998-08-24 2000-02-15 Marco Polo Technologies Compositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the same
SE9901733L (sv) * 1999-05-12 2000-11-13 Akzo Nobel Nv En komposition innehållande karvakrol och tymol för användning som bactericid
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6495512B1 (en) * 2000-06-23 2002-12-17 International Flavors & Fragrances Inc. Salicylaldehyde-containing composition having antimicrobial and fragrancing properties and process for using same
US20020103261A1 (en) * 2000-10-06 2002-08-01 Dusan Ninkov Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
US20030064948A1 (en) * 2001-02-08 2003-04-03 Alfred Fahr Invasomes for therapy of disorders, their preparation and use
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
EP1455768A1 (en) * 2001-12-07 2004-09-15 Eden Research Plc Respiratory infection prevention and treatment with terpene-containing compositions
US20030225003A1 (en) * 2002-04-18 2003-12-04 Dusan Ninkov Antimicrobial therapeutic compositions for oral and topical use
WO2004045572A1 (en) * 2002-11-21 2004-06-03 J.P.M.E.D. Ltd. Compositions for treating infected skin and mucous membrane comprising an anti-microbial agent and an essential oil
WO2004052308A2 (en) * 2002-12-10 2004-06-24 Biosynexus Incorporated Topical anti-infective formulations
US20040151771A1 (en) * 2003-02-04 2004-08-05 Gin Jerry B. Long-lasting, flavored dosage forms for sustained release of beneficial agents within the mouth
WO2005113128A1 (en) * 2004-05-20 2005-12-01 Eden Research Plc Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using them

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716928A (en) * 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
WO2000010390A1 (en) * 1996-02-20 2000-03-02 Badaway Mohammed A Method of enhancing the antimicrobial properties of antibacterial antibiotics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Antibacterial Activity of Essensial Oils and Oleoresins of Spices and Herbs against Pathogens Bacteria in Upper Airway Respiratory Tract;TANAKA,YASUO ET AL;《NIPPON SHOKUHIN KAGAKU GAKKAISHI》;20021231;第9卷(第2期);67-76 *

Also Published As

Publication number Publication date
PT1879655E (pt) 2015-02-24
EP1879655A2 (fr) 2008-01-23
JP5410748B2 (ja) 2014-02-05
WO2006120494A1 (fr) 2006-11-16
CN103356612A (zh) 2013-10-23
BRPI0610125B8 (pt) 2021-05-25
JP2008540507A (ja) 2008-11-20
BRPI0610125B1 (pt) 2020-08-11
ES2530963T3 (es) 2015-03-09
US20080214518A1 (en) 2008-09-04
MA29606B1 (fr) 2008-07-01
BRPI0610125A2 (pt) 2012-09-25
EA014069B1 (ru) 2010-08-30
CA2606875C (fr) 2015-12-15
WO2006120567A3 (fr) 2007-08-23
EP1879655B1 (fr) 2014-11-26
TNSN07424A1 (fr) 2009-03-17
EA200702483A1 (ru) 2008-04-28
CN101175531B (zh) 2011-09-07
DK1879655T3 (en) 2015-02-23
CN102319246A (zh) 2012-01-18
CA2606875A1 (fr) 2006-11-16
CN101175531A (zh) 2008-05-07
WO2006120567A2 (fr) 2006-11-16
CN102319246B (zh) 2013-07-17

Similar Documents

Publication Publication Date Title
CN103356612B (zh) 包含抗菌药以及一种选自麝香草酚、香芹酚的活性物质的药物组合物
US11529361B2 (en) Halogenated salicylanilides for treating Clostridium infections
Durante-Mangoni et al. Do we still need the aminoglycosides?
JP2003527417A (ja) グラム陽性菌感染の治療に使用する殺菌性抗菌方法及び組成物
EP1044006B1 (en) Use of an antimicrobial agent such as taurolidine or taurultam in the manufacture of a medicament to treat a nosocomial microbial infection
EP2714034B1 (en) Compositions comprising cefepime and tazobactam
JP5276653B2 (ja) カルバペネム類を含む殺菌性抗ｍｒｓａ活性医薬組成物
CN107073124A (zh) 增效的抗微生物剂
JP6525999B2 (ja) 抗菌性組成物
EP1790357B1 (en) Perorally administrable antimicrobial composition
CN106794250A (zh) 包含抗菌剂的药物组合物
CA3092144A1 (en) Diphenyl substituted thiophene-2-amide derivatives and pharmaceutical compositions thereof useful as antimicrobial
KR20150038611A (ko) 백본-고리형 펩타이드와의 조합물
KR20160138304A (ko) 항균 물질들을 포함하는 약학 조성물
US20190388437A1 (en) Compositions and methods for treating bone and joint infections
WO2016180919A1 (en) Enhanced antibiotic composition

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant